Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AT&T (T) Q4 Earnings and Revenues Beat Estimates
AT&T (T) Q4 Earnings and Revenues Beat Estimates

AT&T (T) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.54 per share a year ago. These figures are

Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings
Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings

IDEXX Laboratories, Inc. IDXX is set to release fourth-quarter 2025 results on Feb.2, before the opening bell.

In the last reported quarter, the company posted adjusted earnings per share (EPS) of

CGI Group (GIB) Lags Q1 Earnings and Revenue Estimates
CGI Group (GIB) Lags Q1 Earnings and Revenue Estimates

CGI Group (GIB) came out with quarterly earnings of $1.51 per share, missing the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.41 per share a year ago. These figures

Textron (TXT) Q4 Earnings Lag Estimates
Textron (TXT) Q4 Earnings Lag Estimates

Textron (TXT) came out with quarterly earnings of $1.73 per share, missing the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.34 per share a year ago. These figures are

GE Vernova (GEV) Surpasses Q4 Earnings and Revenue Estimates
GE Vernova (GEV) Surpasses Q4 Earnings and Revenue Estimates

GE Vernova (GEV) came out with quarterly earnings of $13.39 per share, beating the Zacks Consensus Estimate of $3.05 per share. This compares to earnings of $1.73 per share a year ago. These figures

Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?
Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?

Boston Scientific BSX is slated to report fourth-quarter 2025 results on Feb. 4, before market open.

The renowned medical device manufacturer posted earnings per share (EPS) of 75 cents in the last

STERIS' Q3 Earnings on Deck: What's in Store for the Stock?
STERIS' Q3 Earnings on Deck: What's in Store for the Stock?

STERIS plc STE is scheduled to release third-quarter fiscal 2026 results on Feb. 4, after market close.

In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.47

KTOS vs. CW: Where Should Investors Place Their Bets Right Now?
KTOS vs. CW: Where Should Investors Place Their Bets Right Now?

As rising global security threats are driving higher defense spending, major defense companies like Kratos Defense & Security Solutions, Inc. KTOS and Curtiss-Wright CW are drawing investor focus

V.F. (VFC) Q3 Earnings and Revenues Surpass Estimates
V.F. (VFC) Q3 Earnings and Revenues Surpass Estimates

V.F. (VFC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.62 per share a year ago. These figures are

Navient (NAVI) Q4 Earnings Top Estimates
Navient (NAVI) Q4 Earnings Top Estimates

Navient (NAVI) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.25 per share a year ago. These figures

Otis Worldwide (OTIS) Q4 Earnings Match Estimates
Otis Worldwide (OTIS) Q4 Earnings Match Estimates

Otis Worldwide (OTIS) came out with quarterly earnings of $1.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.93 per share a year ago. These figures are

This Country's Stock Market Was the World's Top Performer in 2025
This Country's Stock Market Was the World's Top Performer in 2025

Over long periods of time, U.S. stocks have established themselves as among the best performers in global equity markets. In the 20 years ended Jan. 26, 2026, the S&P 500 Index has delivered a

Elevance Health (ELV) Beats Q4 Earnings Estimates
Elevance Health (ELV) Beats Q4 Earnings Estimates

Elevance Health (ELV) came out with quarterly earnings of $3.33 per share, beating the Zacks Consensus Estimate of $3.1 per share. This compares to earnings of $3.84 per share a year ago. These

Danaher (DHR) Beats Q4 Earnings and Revenue Estimates
Danaher (DHR) Beats Q4 Earnings and Revenue Estimates

Danaher (DHR) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.14 per share a year ago. These figures are

Can Gold Fields Maintain Its Upward Gold Production Momentum?
Can Gold Fields Maintain Its Upward Gold Production Momentum?

Gold Fields Ltd. GFI delivered standout third-quarter 2025 results, with a meaningful increase in attributable gold-equivalent production that was a key highlight of the quarter. The company

Koninklijke KPN NV (KKPNF) Meets Q4 Earnings Estimates
Koninklijke KPN NV (KKPNF) Meets Q4 Earnings Estimates

Koninklijke KPN NV (KKPNF) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.05 per share a year ago. These figures are

Central Pacific Financial (CPF) Q4 Earnings and Revenues Top Estimates
Central Pacific Financial (CPF) Q4 Earnings and Revenues Top Estimates

Central Pacific Financial (CPF) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.7 per share a year ago

Is GAMDX a Strong Bond Fund Right Now?
Is GAMDX a Strong Bond Fund Right Now?

Having trouble finding a International Bond - Emerging fund? Well, Goldman Sachs Local Emerging Markets Debt A (GAMDX) would not be a good potential starting point right now. GAMDX has a Zacks

Is Macquarie Small Cap Growth Y (WSCYX) a Strong Mutual Fund Pick Right Now?
Is Macquarie Small Cap Growth Y (WSCYX) a Strong Mutual Fund Pick Right Now?

If investors are looking at the Small Cap Growth fund category, Macquarie Small Cap Growth Y (WSCYX) could be a potential option. WSCYX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is

Is PFIIX a Strong Bond Fund Right Now?
Is PFIIX a Strong Bond Fund Right Now?

There are plenty of choices in the Government Mortgage - Short category, but where should you start your research? Well, one fund that might be worth investigating is PIMCO Low Duration Income Ins

Is PIFZX a Strong Bond Fund Right Now?
Is PIFZX a Strong Bond Fund Right Now?

Investment Grade Bond - Short fund seekers may want to consider taking a look at PGIM Short-Term Corporate Bond Z (PIFZX). PIFZX bears a Zacks Mutual Fund Rank of 3 (Hold), which is based on various

Is Fidelity Advisor New Insights I (FINSX) a Strong Mutual Fund Pick Right Now?
Is Fidelity Advisor New Insights I (FINSX) a Strong Mutual Fund Pick Right Now?

If you're looking for a Large Cap Growth fund category, then a potential option is Fidelity Advisor New Insights I (FINSX). FINSX holds a Zacks Mutual Fund Rank of 3 (Hold), which is based on

Micron Bets Big on Memory Growth With $24B Singapore Expansion
Micron Bets Big on Memory Growth With $24B Singapore Expansion

On Tuesday, Micron Technology, Inc.’s MU shares climbed 5.4% after it announced plans to invest about $24 billion to build a new advanced memory chip fabrication facility in Singapore, reinforcing

Is Invesco S&P 500 Equal Weight Energy ETF (RSPG) a Strong ETF Right Now?
Is Invesco S&P 500 Equal Weight Energy ETF (RSPG) a Strong ETF Right Now?

Making its debut on 11/01/2006, smart beta exchange traded fund Invesco S&P 500 Equal Weight Energy ETF (RSPG) provides investors broad exposure to the Energy ETFs category of the market.

What Are

Should Vanguard Small-Cap Value ETF (VBR) Be on Your Investing Radar?
Should Vanguard Small-Cap Value ETF (VBR) Be on Your Investing Radar?

Launched on January 26, 2004, the Vanguard Small-Cap Value ETF (VBR) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Value segment of the US equity